These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 34028255)

  • 1. Comparing the Pfizer Central Nervous System Multiparameter Optimization Calculator and a BBB Machine Learning Model.
    Urbina F; Zorn KM; Brunner D; Ekins S
    ACS Chem Neurosci; 2021 Jun; 12(12):2247-2253. PubMed ID: 34028255
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Moving beyond rules: the development of a central nervous system multiparameter optimization (CNS MPO) approach to enable alignment of druglike properties.
    Wager TT; Hou X; Verhoest PR; Villalobos A
    ACS Chem Neurosci; 2010 Jun; 1(6):435-49. PubMed ID: 22778837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ensemble modeling with machine learning and deep learning to provide interpretable generalized rules for classifying CNS drugs with high prediction power.
    Yu TH; Su BH; Battalora LC; Liu S; Tseng YJ
    Brief Bioinform; 2022 Jan; 23(1):. PubMed ID: 34530437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A method to predict different mechanisms for blood-brain barrier permeability of CNS activity compounds in Chinese herbs using support vector machine.
    Jiang L; Chen J; He Y; Zhang Y; Li G
    J Bioinform Comput Biol; 2016 Feb; 14(1):1650005. PubMed ID: 26632324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Central Nervous System Multiparameter Optimization Desirability: Application in Drug Discovery.
    Wager TT; Hou X; Verhoest PR; Villalobos A
    ACS Chem Neurosci; 2016 Jun; 7(6):767-75. PubMed ID: 26991242
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Machine Learning Exploration of the Relationship Between Drugs and the Blood-Brain Barrier: Guiding Molecular Modification.
    Yang Q; Fan L; Hao E; Hou X; Deng J; Xia Z; Du Z
    Pharm Res; 2024 May; 41(5):863-875. PubMed ID: 38605261
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Bayesian approach to in silico blood-brain barrier penetration modeling.
    Martins IF; Teixeira AL; Pinheiro L; Falcao AO
    J Chem Inf Model; 2012 Jun; 52(6):1686-97. PubMed ID: 22612593
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrating in Silico and in Vitro Approaches To Predict Drug Accessibility to the Central Nervous System.
    Zhang YY; Liu H; Summerfield SG; Luscombe CN; Sahi J
    Mol Pharm; 2016 May; 13(5):1540-50. PubMed ID: 27015243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Blood-Brain Barrier (BBB) Score.
    Gupta M; Lee HJ; Barden CJ; Weaver DF
    J Med Chem; 2019 Nov; 62(21):9824-9836. PubMed ID: 31603678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediction of the Blood-Brain Barrier (BBB) Permeability of Chemicals Based on Machine-Learning and Ensemble Methods.
    Liu L; Zhang L; Feng H; Li S; Liu M; Zhao J; Liu H
    Chem Res Toxicol; 2021 Jun; 34(6):1456-1467. PubMed ID: 34047182
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Empirical Analysis of Drug Targets for Nervous System Disorders.
    Mueller LG; Slusher BS; Tsukamoto T
    ACS Chem Neurosci; 2024 Feb; 15(3):394-399. PubMed ID: 38237559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contribution assessment of multiparameter optimization descriptors in CNS penetration.
    Raevsky OA; Grigorev VY; Polianczyk DE; Raevskaja OE; Dearden JC
    SAR QSAR Environ Res; 2018 Oct; 29(10):785-800. PubMed ID: 30274532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CNS Multiparameter Optimization Approach: Is it in Accordance with Occam's Razor Principle?
    Raevsky OA
    Mol Inform; 2016 Apr; 35(3-4):94-8. PubMed ID: 27491918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In Silico Prediction of Blood-Brain Barrier Permeability of Compounds by Machine Learning and Resampling Methods.
    Wang Z; Yang H; Wu Z; Wang T; Li W; Tang Y; Liu G
    ChemMedChem; 2018 Oct; 13(20):2189-2201. PubMed ID: 30110511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved Prediction of Blood-Brain Barrier Permeability Through Machine Learning with Combined Use of Molecular Property-Based Descriptors and Fingerprints.
    Yuan Y; Zheng F; Zhan CG
    AAPS J; 2018 Mar; 20(3):54. PubMed ID: 29564576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Resampling combined with stacking learning for prediction of blood-brain barrier permeability of compounds].
    Su Q; Xiao G; Zhou W; Du Z
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2023 Aug; 40(4):753-761. PubMed ID: 37666766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Application of in vitro PAMPA technique and in silico computational methods for blood-brain barrier permeability prediction of novel CNS drug candidates.
    Radan M; Djikic T; Obradovic D; Nikolic K
    Eur J Pharm Sci; 2022 Jan; 168():106056. PubMed ID: 34740787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Finding Needles in a Haystack: Determining Key Molecular Descriptors Associated with the Blood-brain Barrier Entry of Chemical Compounds Using Machine Learning.
    Majumdar S; Basak SC; Lungu CN; Diudea MV; Grunwald GD
    Mol Inform; 2019 Aug; 38(8-9):e1800164. PubMed ID: 31322827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-animal models for blood-brain barrier permeability evaluation of drug-like compounds.
    Dehnbostel FO; Dixit VA; Preissner R; Banerjee P
    Sci Rep; 2024 Apr; 14(1):8908. PubMed ID: 38632344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In silico modeling on ADME properties of natural products: Classification models for blood-brain barrier permeability, its application to traditional Chinese medicine and in vitro experimental validation.
    Zhang X; Liu T; Fan X; Ai N
    J Mol Graph Model; 2017 Aug; 75():347-354. PubMed ID: 28628860
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.